Scalper1 News
Celgene (CELG) kicks off a slew of major earnings reports, even if it isn’t on the official calendar. The biotech will “present unaudited 2013 financial results” and an updated financial outlook Monday morning at the J.P. Morgan Healthcare Conference in San Francisco. At last year’s JPMorgan conference, Celgene issued bullish financial guidance through 2017 as well as some drug trial information. Celgene is just one of many medical companies to Scalper1 News
Scalper1 News